ERLANGER Home
MyErlangerHealth HealthLink Plus For Vendors For the Media Physician Relations and Recruitment
975 East Third Street
Chattanooga, TN 37403
423-778-7000
Children's Hospital at Erlanger Erlanger Baroness Campus Erlanger Bledsoe Campus Erlanger East Campus Erlanger North Campus UT Erlanger Physicians Group





Online Prereg
Register for a Class or Event
New Foundations Page
Print   Email
Head & Neck

Head and Neck Cancer Studies

 E1305                               Principal Investigator: Larry Schlabach, MD

                                                Co-Investigator: John McCravey, MD and Matt Graham, MD

Title: A Phase III Randomised Trial of chemotherapy With or WithoutBevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer. (IRB#: 08-106)

NCT #: NCT00588770        Phase: Phase III

Purpose:This randomized phase III trial is studying chemotherapy to see how well it works with or without bevacizumab in treating patients with recurrent or metastatic head and neck cancer. 

Drugs possibly given:
Bevacizumab
Carboplatin
Cisplatin
Docetaxel
Fluorouracil

Please view complete information about this trial at: http://www.clinicaltrial.gov/ct2/show/NCT00588770?term=E1305&rank=1